12-101285817-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014503.3(UTP20):āc.262A>Gā(p.Ile88Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014503.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP20 | NM_014503.3 | c.262A>G | p.Ile88Val | missense_variant | 4/62 | ENST00000261637.5 | NP_055318.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP20 | ENST00000261637.5 | c.262A>G | p.Ile88Val | missense_variant | 4/62 | 1 | NM_014503.3 | ENSP00000261637 | P1 | |
UTP20 | ENST00000551825.1 | n.417A>G | non_coding_transcript_exon_variant | 4/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251204Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135764
GnomAD4 exome AF: 0.0000903 AC: 132AN: 1461598Hom.: 0 Cov.: 32 AF XY: 0.0000839 AC XY: 61AN XY: 727100
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.262A>G (p.I88V) alteration is located in exon 4 (coding exon 4) of the UTP20 gene. This alteration results from a A to G substitution at nucleotide position 262, causing the isoleucine (I) at amino acid position 88 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at